The range of options for children aged six months & older & the first & only adjuvanted seasonal influenza vaccine developed for people aged 65 & older.
Dr. Sylvester joined Seqirus in 2016 as Vice President of Medical Affairs. Prior to this, he held a variety of senior management positions, including Global Medical Lead for Pfizer’s pediatric pneumococcal vaccine and Worldwide Medical Lead for Merck’s HPV vaccine and Cabinet Secretary for Delaware’s Health & Social Services. Gregg is a preventive medicine expert with a passion for disease prevention and health promotion on a local, statewide, and global basis. He has focused his career on developing sound health policy, implementing innovative public health programs and accelerating vaccine use worldwide.